ARTICLE
- CNBC
(2020)
The ACTIV-3 trial is one of several ongoing trials that are part of an NIH program to accelerate the development of vaccine treatments.
Visibility: Public (all visitors)
Related Chunks
Related chunks with this resource
Saved by FoundryBase
Contains: 6 resources
Contains: 6 resources
No comments yet. Be the first to comment!